PROTALIX BIOTHERAPEUTICS INC (PLX) Forecast, Price Target & Analyst Ratings

NYSEARCA:PLXUS74365A3095

Current stock price

2.16 USD
+0.09 (+4.35%)
At close:
2.16 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROTALIX BIOTHERAPEUTICS INC (PLX).

Forecast Snapshot

Consensus Price Target

Price Target
$11.22
+ 419.44% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.04
Revenue Estimate
18.887M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.22
Upside
+ 419.44%
From current price of $2.16 to mean target of $11.22, Based on 5 analyst forecasts
Low
$10.10
Median
$11.22
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
-12.00%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for PLX. The average price target is 11.22 USD. This implies a price increase of 419.44% is expected in the next year compared to the current price of 2.16.
The average price target has been revised downward by 12% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

PLX Current Analyst RatingPLX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

PLX Historical Analyst RatingsPLX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
PLX was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PLX.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed PLX. So this is just the average opinion of a couple of analysts.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-21HC Wainwright & Co.Maintains Buy -> Buy
2025-02-03HC Wainwright & Co.Maintains Buy -> Buy
2023-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-31HC Wainwright & Co.Maintains Buy -> Buy
2021-05-03HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.04
Revenue Estimate
18.887M
Revenue Q2Q
86.76%
EPS Q2Q
180.80%
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-14.55%
EPS (1 Month)
0.00%
EPS (3 Months)
-85.71%

Next Earnings Summary

PLX is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.04 USD and the consensus revenue estimate is 18.89M USD.
The next earnings revenue estimate has been revised downward by 14.55% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
PLX revenue by date.PLX revenue by date.
47.64M
24.22%
65.494M
37.48%
53.399M
-18.47%
58.561M
9.67%
72.531M
23.86%
73.44M
1.25%
EBITDA
YoY % growth
PLX ebitda by date.PLX ebitda by date.
-11.92M
38.37%
11.651M
197.74%
5.221M
-55.19%
N/AN/AN/A
EBIT
YoY % growth
PLX ebit by date.PLX ebit by date.
-13.01M
36.41%
10.46M
180.40%
3.917M
-62.55%
-836.785K
-121.36%
4.774M
670.52%
6.427M
34.63%
Operating Margin
PLX operating margin by date.PLX operating margin by date.
-27.31%15.97%7.34%-1.43%6.58%8.75%
EPS
YoY % growth
PLX eps by date.PLX eps by date.
N/A
37.48%
0.05
112.69%
0.03
-40.00%
-0.01
-400.00%
0.07
178.56%
0.08
14.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.04
180.80%
0.050.05
68.33%
0.06
186.57%
Revenue
Q2Q % growth
18.887M
86.76%
19.695M
25.78%
20.301M
13.72%
21.109M
131.41%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PLX Yearly Revenue VS EstimatesPLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
PLX Yearly EPS VS EstimatesPLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

PROTALIX BIOTHERAPEUTICS INC / PLX Forecast FAQ

What is the average price target for PROTALIX BIOTHERAPEUTICS INC (PLX) stock?

5 analysts have analysed PLX and the average price target is 11.22 USD. This implies a price increase of 419.44% is expected in the next year compared to the current price of 2.16.

Can you provide the upcoming earnings date for PROTALIX BIOTHERAPEUTICS INC?

PROTALIX BIOTHERAPEUTICS INC (PLX) will report earnings on 2026-05-07.

What are the consensus estimates for PLX stock next earnings?

The consensus EPS estimate for the next earnings of PROTALIX BIOTHERAPEUTICS INC (PLX) is 0.04 USD and the consensus revenue estimate is 18.89M USD.